Discover 1,584 paid clinical trials in Aurora, Colorado. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,584
Active & Responsive
Restarting Triple Therapy With Robust Monitoring for Adverse Events (RETRIAL)
for
Cystic Fibrosis
Location: Aurora CO, Denver CO, Kansas City KS, Dallas TX,
Sponsor: Boston Children's Hospital
Sex: All
Age: 6+
Code: NCT06683092
Recruiting
Active & Responsive
A Clinical Study of Letermovir (MK-8228) in Children and Adolescents Who Receive a Kidney Transplant (KT) (MK-8228-077)
for
Cytomegalovirus Prophylaxis
Location: Aurora CO, Minneapolis MN, Rochester MN, Los Angeles CA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 0 - 17
Code: NCT07199465
Phase1, Recruiting
Active & Responsive
A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome
for
Dravet Syndrome
Location: Aurora CO, Salt Lake City UT, Phoenix AZ, Fort Worth TX,
Location: Denver CO, Salt Lake City UT, Omaha NE, Kansas City MO,
Sponsor: Mezzion Pharma Co. Ltd
Sex: All
Age: 12 - 18
Code: NCT05918211
Phase3, Recruiting
Active & Responsive
Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma
for
Pleuropulmonary Blastoma
Location: Aurora CO, Denver CO, Salt Lake City UT, Lubbock TX,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 21
Code: NCT06647953
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Location: Aurora CO, Phoenix AZ, Dallas TX, St Louis MO,
Sponsor: Rocket Pharmaceuticals Inc.
Sex: All
Age: 8+
Code: NCT06214507
Recruiting
Active & Responsive
A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation (The ReInspire Study)
for
PIK3CA-Related Overgrowth Spectrum (PROS),
Location: Aurora CO, Phoenix AZ, Rochester MN, Iowa City IA,
Sponsor: Relay Therapeutics, Inc.
Sex: All
Age: 2+
Code: NCT06789913
Phase2, Recruiting
Active & Responsive
OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages
for
Eosinophilic Gastrointestinal Disorders (EGIDs),
Location: Denver CO, Aurora CO, Salt Lake City UT, Phoenix AZ,
Sponsor: Children's Hospital Medical Center, Cincinnati
Sex: All
Age: 3+
Code: NCT02523118
Recruiting
Active & Responsive
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
for
Plasma Cell Myeloma
Location: Aurora CO, Lakewood CO, Longmont CO,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 0+
Code: NCT05561387
Phase3, Recruiting
Active & Responsive
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
for
Diabetes Mellitus, Type 2, Hypertension,
Location: Aurora CO, Albuquerque NM, Salt Lake City UT,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT07064473
Phase3, Recruiting
Active & Responsive
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
for
Metastatic Castrate Resistant Prostate Cancer,
Location: Aurora CO, Kansas City MO, Boise ID, Minneapolis MN,
Sponsor: VA Office of Research and Development
Sex: Male
Age: 18+
Code: NCT04038502
Phase2, Recruiting
Active & Responsive
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
for
Prostate Cancer, Prostatic Neoplasms
Location: Aurora CO, Albuquerque NM, Billings MT, Phoenix AZ,
Sponsor: Merck Sharp & Dohme LLC
Sex: Male
Age: 18+
Code: NCT06925737
Phase3, Recruiting
Active & Responsive
Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS
for
Amyotrophic Lateral Sclerosis
Location: Aurora CO, Lincoln NE, Fairway KS, Phoenix AZ,
Sponsor: Prilenia
Sex: All
Age: 18 - 70+
Code: NCT07322003
Phase3, Recruiting
Active & Responsive
Study of ALK-001 on the Progression of Stargardt Disease
for
Stargardt Disease
Location: Aurora CO, Phoenix AZ, Fort Worth TX, Dallas TX,
Sponsor: Alkeus Pharmaceuticals, Inc.
Sex: All
Age: 8 - 45
Code: NCT07419334
Phase3, Recruiting
Active & Responsive
CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma
for
Relapsed/Refractory Multiple Myeloma
Location: Aurora CO, Salt Lake City UT, Dallas TX, Milwaukee WI,
Sponsor: Caribou Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT05722418
Phase1, Recruiting
Active & Responsive
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
for
Crohn's Disease
Location: Aurora CO, Englewood CO, Lakewood CO,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 16 - 70+
Code: NCT06430801
Phase3, Recruiting
Active & Responsive
A Phase 1/3 Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation
Early Rebiopsy to Identify Biomarkers of Tumor Cell Survival Following EGFR, ALK, ROS1 or BRAF TKI Therapy
for
Non-Small Cell Carcinoma of Lung, TNM Stage 4,
Location: Aurora CO
Sponsor: University of Colorado, Denver
Sex: All
Age: 18 - 70+
Code: NCT03042221
Recruiting
Active & Responsive
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
for
Non-small Cell Lung Cancer
Location: Aurora CO, Lincoln NE, Billings MT, Sioux Falls SD,